<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:91.2pt;left:60.7pt;line-height:13.0pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:13.0pt;color:#ffffff">REVIEW</span></p>
<p style="top:91.2pt;left:461.4pt;line-height:13.0pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:13.0pt;color:#ffffff">Open Access</span></p>
<img style="position:absolute;transform:matrix(1.3333334,0,0,1.3333334,669,157.66667)" src="data:image/png;base64,
iVBORw0KGgoAAAANSUhEUgAAACsAAAAqCAYAAAAqAaJlAAAACXBIWXMAAA7EAAAO
xAGVKw4bAAAA1ElEQVR4nNXDiw5CAAAF0Pv/H1bpRRm9SEWIGaMYxu077tkOoGSe
Z6rENE1UiXEcqRLDMFAl+r6nSnRdR5Vo25Yq8f39qBJN01Al6rqmSlRVRZUoy5Iq
URQFVSLPc6pElmVUiTT9UCWSJKVKxHFClYiiN1UiDCOqxOsVUiWejydVIggeVIm7
H1AlfM+nSng3jypxvVypEufzhSrhuieqhOO4VAnbdqgSx4NNlThYR6qEZVpUCXNv
UiX2O5Mqsd3sqBKb9ZYqYRhrqsRyaVAlFosVVf4BJ9Uc9i1sdQQAAAAASUVORK5CYII=">
<p style="top:120.9pt;left:56.7pt;line-height:23.4pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:23.4pt;color:#131313">Are ketogenic diets promising for</span></p>
<p style="top:146.9pt;left:56.7pt;line-height:23.4pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:23.4pt;color:#131313">Alzheimer</span><span style="font-family:TdvqrrAdvTTe45e47d2+20,serif;font-size:23.4pt;color:#131313">&#x2019;</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:23.4pt;color:#131313">s disease? A translational review</span></p>
<p style="top:181.0pt;left:56.7pt;line-height:10.7pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">Matthieu Lilamand</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2,3*</span></sup><sup><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.6pt;color:#131313">&#x2020;</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">, Baptiste Porte</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2</span></sup><sup><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.6pt;color:#131313">&#x2020;</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">, Emmanuel Cognat</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">, Jacques Hugon</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">, Fran&#xe7;ois Mouton-Liger</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2</span></sup><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313"> </span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">and</span></p>
<p style="top:195.0pt;left:56.7pt;line-height:10.7pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.7pt;color:#131313">Claire Paquet</span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.6pt;color:#131313">1,2</span></sup></p>
<p style="top:233.8pt;left:63.2pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Abstract</span></p>
<p style="top:252.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:10.0pt;color:#131313">Background:</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313"> Brain amyloid deposition and neurofibrillary tangles in Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:10.0pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">s disease (AD) are associated with</span></p>
<p style="top:264.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is</span></p>
<p style="top:276.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and</span></p>
<p style="top:288.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the</span></p>
<p style="top:300.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy,</span></p>
<p style="top:312.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and</span></p>
<p style="top:324.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce.</span></p>
<p style="top:336.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in</span></p>
<p style="top:348.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">AD and ageing animal models and in humans.</span></p>
<p style="top:363.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:10.0pt;color:#131313">Main body:</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313"> We conducted a review based on a systematic search of interventional trials published from January</span></p>
<p style="top:375.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were</span></p>
<p style="top:387.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor</span></p>
<p style="top:399.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also</span></p>
<p style="top:411.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">associated with significant weight loss. In human studies, most of the published articles showed a significant</span></p>
<p style="top:423.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone</span></p>
<p style="top:435.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions</span></p>
<p style="top:447.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">seemed acceptable and efficient to achieve ketosis.</span></p>
<p style="top:462.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:10.0pt;color:#131313">Conclusion:</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313"> The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the</span></p>
<p style="top:474.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD</span></p>
<p style="top:486.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these</span></p>
<p style="top:498.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">nutritional approaches.</span></p>
<p style="top:515.1pt;left:63.2pt;line-height:10.0pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:10.0pt;color:#131313">Keywords:</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313"> Ketogenic diet, Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:10.0pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:10.0pt;color:#131313">s disease, Brain metabolism, Animal models</span></p>
<img style="position:absolute;transform:matrix(.319947,0,-0,.31894506,14.7313389,805.9281)" src="data:image/jpeg;base64,
/9j/7gAOQWRvYmUAZIAAAAAB/9sAhAAGBAQEBQQGBQUGCQYFBgkLCAYGCAsMCgoL
CgoMEAwMDAwMDBAMDg8QDw4MExMUFBMTHBsbGxwfHx8fHx8fHx8fAQcHBw0MDRgQ
EBgaFREVGh8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f
Hx8fHx8fHx//wAARCAC2ALADAREAAhEBAxEB/8QBogAAAAcBAQEBAQAAAAAAAAAA
BAUDAgYBAAcICQoLAQACAgMBAQEBAQAAAAAAAAABAAIDBAUGBwgJCgsQAAIBAwMC
BAIGBwMEAgYCcwECAxEEAAUhEjFBUQYTYSJxgRQykaEHFbFCI8FS0eEzFmLwJHKC
8SVDNFOSorJjc8I1RCeTo7M2F1RkdMPS4ggmgwkKGBmElEVGpLRW01UoGvLj88TU
5PRldYWVpbXF1eX1ZnaGlqa2xtbm9jdHV2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4
KTlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+hEAAgIBAgMFBQQFBgQIAwNtAQAC
EQMEIRIxQQVRE2EiBnGBkTKhsfAUwdHhI0IVUmJy8TMkNEOCFpJTJaJjssIHc9I1
4kSDF1STCAkKGBkmNkUaJ2R0VTfyo7PDKCnT4/OElKS0xNTk9GV1hZWltcXV5fVG
VmZ2hpamtsbW5vZHV2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4OUlZaXmJmam5ydnp
+So6SlpqeoqaqrrK2ur6/9oADAMBAAIRAxEAPwD1TirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVd
irsVdirsVdirsVdiq1pY1NGYA+BOKthlPQ1xVvFXYq7FXYq7FXYq7FXYq7FXYq7F
XYq7FXYq7FXYq7FXYq7FVsjhEZj2FcVedatq9z+kHYOaV2FcVTrQ9e5gK7YqymGZ
ZFBBxVUxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KoXU5OFm/uMVeX
ao1bhvngVRtbp4XBBxVmWha6GCoxwqyuGZZFBBxVUxV2KuxV2KuxV2KuxV2KuxV2
KuxV2KuxV2KuxV2KuxVLdbelsw9sVeZ6iazt88CoXFVe2uXhcEGmKsy0LXQwCucK
srhmWRQQcVVMVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdiqUa+1LdsVebXpr
M3zwKh8VaxVEW1y8Lgg4VZjoWuggKxxVlkMySKCDiqpirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdiqSeYmpbn5Yq84uj+9bAqjirsVdiqvbXLwuCDhVmOha6CAjNir
LIJ0kUEHFVTFXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYqx/zK1ITirzuc/vDgVTx
V2KuxV2Kq9tcvC4IOFWYaFrtaKzYqyyCdJUBBxVVxV2KuxV2KuxV2KuxV2KuxV2K
uxV2KuxVjXmhqRHArz+b7ZxVZirsVdirsVdiqvbXLxOCDirMdC1skBWOKsshmWRA
RhVUxV2KuxV2KuxV2KuxV2KuxV2KuxVxxVivmlvgOBWByfaOKrcVdirsVdirsVdi
qItbp4XBBxVmWha6GCqxxVlUMyyKCDhVUxV2KuxV2KuxV2KuxV2KuxV2KuPTFWH+
a22IxVhD/aOBWsVdirsVdirsVdirsVRFrdPC4IOKsy0LXQQEY4VZVDMsigg4qqYq
7FXYq7FXYq7FXYq7FXYq032TirC/NbbnArDW6nFWsVdirsVdirsVdirsVdiqva3T
wuCDirMtC10MAjNhVlcMyyKCDiqpirsVdirsVdirsVdirsVaf7JxVgvmpviOKsSP
XArsVdirsVdirsVdirsVdirsVV7a5eJwQcVZloWu8uKMcKsticOgYdDiq7FXYq7F
XYq7FXYq7FVsv2DirAfNLVkOKsXOBXYq7FXYq7FXYq6hxVvi3hiq4ROe2KrhbSns
cVVFsJz+ycVTDT9PvRKvBTWuFXo9gkiWkayfbA3xVEYq7FXYq7FXYq7FXYqsm/uz
irz7zLUzHFWO+k57YFXi2lPRcVVFsJj+ycKqyaTcN+ycVV49BuG/ZOKoqPy1O3Vc
VRcXlWQ9VwKi4vKR7jCqMi8qxjqMVRMfluBeoGKoqPQrVeqjFUZBZW8P2EFfHFVf
FXYq7FXYq7FXYq7FXYqtkXkpGKpBqGhfWJCaYqoReVUHUYqi4/LUA6gYqiY9BtV7
DFUQmlWq/sjFVVbK3XooxVUEMY6KMVXBVHbFW8VdirsVdirsVdirsVdirsVdirsV
dirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirs
VdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdir
sVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdirsVdi
rsVdirsVdirsVdirsVdirsVdir//2Q==">
<img style="position:absolute;transform:matrix(.31997533,0,-0,.31813593,84.375339,844.48818)" src="data:image/png;base64,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">
<p style="top:661.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">&#xa9; The Author(s). 2020</span><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:6.8pt;color:#131313"> Open Access</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313"> This article is licensed under a Creative Commons Attribution 4.0 International License,</span></p>
<p style="top:669.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give</span></p>
<p style="top:677.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if</span></p>
<p style="top:685.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">changes were made. The images or other third party material in this article are included in the article&apos;s Creative Commons</span></p>
<p style="top:693.8pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&apos;s Creative Commons</span></p>
<p style="top:701.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain</span></p>
<p style="top:709.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">permission directly from the copyright holder. To view a copy of this licence, visit</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#0000ff"> http://creativecommons.org/licenses/by/4.0/</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">.</span></p>
<p style="top:717.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">The Creative Commons Public Domain Dedication waiver (</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#0000ff">http://creativecommons.org/publicdomain/zero/1.0/</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">) applies to the</span></p>
<p style="top:725.9pt;left:180.3pt;line-height:6.8pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:6.8pt;color:#131313">data made available in this article, unless otherwise stated in a credit line to the data.</span></p>
<p style="top:581.6pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">* Correspondence:</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#0000ff"> mlilamand@hotmail.fr</span></p>
<p style="top:589.0pt;left:56.7pt;line-height:5.3pt"><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:5.3pt">&#x2020;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Matthieu Lilamand and Baptiste Porte contributed equally to this work.</span></p>
<p style="top:598.0pt;left:56.7pt;line-height:5.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt">1</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">INSERM U1144 Optimisation Th&#xe9;rapeutique en Neuropsychopharmacologie,</span></p>
<p style="top:608.6pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Universit&#xe9; de Paris, Paris, France</span></p>
<p style="top:616.0pt;left:56.7pt;line-height:5.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt">2</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Centre de Neurologie Cognitive/CMRR Paris Nord Ile de France, APHP Nord</span></p>
<p style="top:626.6pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Universit&#xe9; de Paris, Lariboisi&#xe8;re Hospital 200, rue du Faubourg Saint Denis,</span></p>
<p style="top:635.5pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">75010 Paris, France</span></p>
<p style="top:644.6pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Full list of author information is available at the end of the article</span></p>
<img style="position:absolute;transform:matrix(.3199981,0,-0,.32,264.07008,1.9093399)" src="data:image/png;base64,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">
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:42.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">https://doi.org/10.1186/s13195-020-00615-4</span></p>


<p style="top:87.1pt;left:56.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Background</span></p>
<p style="top:99.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Carbohydrates represent the primary energy source for</span></p>
<p style="top:111.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the brain. However, when glucose is not readily available</span></p>
<p style="top:123.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(e.g. starvation), a metabolic switch occurs in favour of</span></p>
<p style="top:135.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ketone bodies (KB), usually released by the liver. The di-</span></p>
<p style="top:147.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ets specifically designed for KB production are called ke-</span></p>
<p style="top:159.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">togenic diets (KDs) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">1</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 2</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. They are the first and only</span></p>
<p style="top:171.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">nutritional interventions that enabled a significant re-</span></p>
<p style="top:183.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">duction in the incidence of seizures in pharmacoresis-</span></p>
<p style="top:195.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tant epilepsy [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">3</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] or in chronic cluster headaches [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">4</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. The</span></p>
<p style="top:207.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">core characteristics of the KD are the association of a</span></p>
<p style="top:219.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">high amount of fat, with low carbohydrate intake, usually</span></p>
<p style="top:231.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">a macronutrient ratio of fat to protein and carbohydrate</span></p>
<p style="top:243.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">combined equal to 3</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2013;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">4:1. Alternative KDs were devel-</span></p>
<p style="top:255.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">oped using ketone supplementation (KS), in which fats</span></p>
<p style="top:267.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">are provided with medium-chain triglyceride (MCT) in-</span></p>
<p style="top:279.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">take. Their common objective is to achieve ketosis, lead-</span></p>
<p style="top:291.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ing to reduced insulin secretion and glycaemia within</span></p>
<p style="top:303.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">48 h, as well as a shift in the brain</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">s metabolism [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">2</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:315.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">In Alzheimer</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">s disease (AD), it is described numerous</span></p>
<p style="top:327.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">interrelations between abnormal glucose metabolism</span></p>
<p style="top:339.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and the occurrence of brain lesions. First, AD could be a</span></p>
<p style="top:351.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">partial consequence of insulin resistance, which affects</span></p>
<p style="top:363.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">insulin signalling and favours in the brain abnormal de-</span></p>
<p style="top:375.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">position of</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313"> &#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">-amyloid peptide (A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">) and phosphorylated</span></p>
<p style="top:387.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tau (pTau) accumulation, leading in turn to cognitive</span></p>
<p style="top:399.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">decline [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">5</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Furthermore, the expression of apolipopro-</span></p>
<p style="top:411.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tein E allele 4 (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">APOE4</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">) is a common risk factor for AD</span></p>
<p style="top:423.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and for type 2 diabetes suggesting a common patho-</span></p>
<p style="top:435.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">physiological background [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">6</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. As demonstrated by fluoro-</span></p>
<p style="top:447.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">deoxyglucose positron emission tomography (FDG-PET),</span></p>
<p style="top:459.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">abnormal brain glucose metabolism in the temporal and</span></p>
<p style="top:471.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">parietal lobes occurs from the earliest stages in AD animal</span></p>
<p style="top:483.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">models and AD patients but also in asymptomatic individ-</span></p>
<p style="top:495.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">uals at risk for AD [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">7</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Interestingly, these hypometabolic</span></p>
<p style="top:507.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">regions are still able to take up KB, even though they can</span></p>
<p style="top:519.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">no longer utilize glucose [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">8</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:531.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">At the cellular level, several KD neuroprotective effects</span></p>
<p style="top:543.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">have been observed, linked to various mechanisms: (i)</span></p>
<p style="top:555.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">reduction of the concentration of several excitatory neu-</span></p>
<p style="top:567.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">rotransmitters (e.g. glutamate) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">9</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], (ii) stabilization of</span></p>
<p style="top:579.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">synaptic functions due to enhanced mitochondrial bio-</span></p>
<p style="top:591.4pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">genesis [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">10</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] and (iii) reduction of reactive oxygen species</span></p>
<p style="top:603.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">generation and increase adenosine triphosphate avail-</span></p>
<p style="top:615.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ability [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">11</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Moreover, KB have specific protective effects</span></p>
<p style="top:627.4pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">against cerebral A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> toxicity and cell damage as shown in</span></p>
<p style="top:639.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">rat cultured hippocampal neurons [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">12</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> can induce</span></p>
<p style="top:651.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">neuroinflammation, which is a current therapeutic target</span></p>
<p style="top:663.4pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in AD. KD could modulate A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> toxicity by promoting the</span></p>
<p style="top:675.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">action of endogenous anti-inflammatory molecules such</span></p>
<p style="top:687.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">as peroxisome proliferator-activated receptor</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313"> &#x3b3;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">, leading</span></p>
<p style="top:699.4pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to a decreased systemic inflammation [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">13</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:711.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">These observations, as well as the current lack of suc-</span></p>
<p style="top:723.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cess of anti-AD therapies or nutritional interventions to</span></p>
<p style="top:87.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">change the course of AD, suggest that KD or KS might</span></p>
<p style="top:99.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">be of therapeutic interest in these patients. A potential</span></p>
<p style="top:111.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">benefit of KDs in AD was already claimed in media and</span></p>
<p style="top:123.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">some scientific reports [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">14</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 15</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. However, as few works</span></p>
<p style="top:135.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">have brought about a critical review of existing data, we</span></p>
<p style="top:147.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">hereby propose a comprehensive and translational re-</span></p>
<p style="top:159.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">view of KD efficiency in both preclinical and clinical AD</span></p>
<p style="top:171.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">or ageing studies. Thus, the main objective of this review</span></p>
<p style="top:183.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">was to assess the effects of ketogenic interventions on</span></p>
<p style="top:195.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">clinical and metabolic outcomes (e.g. cognitive function,</span></p>
<p style="top:207.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">brain metabolism) or AD biomarkers, both in experi-</span></p>
<p style="top:219.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mental animals and in humans. We will also examine</span></p>
<p style="top:231.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the potential side effects of ketogenic interventions in</span></p>
<p style="top:243.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">these populations, in terms of nutritional change and ad-</span></p>
<p style="top:255.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">verse effects.</span></p>
<p style="top:279.1pt;left:304.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Research process</span></p>
<p style="top:291.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">We performed a systematic search in accordance with</span></p>
<p style="top:303.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the Preferred Reporting Items for Systematic Reviews</span></p>
<p style="top:315.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and Meta-Analyses (PRISMA) guidelines [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">16</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. We iden-</span></p>
<p style="top:327.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tified all published articles between January 2000 and</span></p>
<p style="top:339.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">March 2019 on MEDLINE and Cochrane databases</span></p>
<p style="top:351.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">using the Medical Subject Heading (MeSH) terms</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">keto-</span></p>
<p style="top:363.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">genic diet</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> or</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">medium-chain triglyceride</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> and assorted</span></p>
<p style="top:375.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">combinations of the following terms:</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Alzheimer</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">s dis-</span></p>
<p style="top:387.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ease</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Alzheimer</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cognition</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> and/or</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313"> &#x201c;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">memory</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x201d;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">. We only</span></p>
<p style="top:399.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">included interventional studies using either KD or KS. We</span></p>
<p style="top:411.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">have excluded studies published in languages other than</span></p>
<p style="top:423.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">English, focusing on KD diet effects in diseases other than</span></p>
<p style="top:435.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">AD or performed in cellular models. Titles and abstracts</span></p>
<p style="top:447.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">were the base of the initial screening. We evaluated the</span></p>
<p style="top:459.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">eligibility of selected articles after full-text readings. We</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">also examined all papers cited in the selected articles. We</span></p>
<p style="top:483.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">added additional references, based on their originality</span></p>
<p style="top:495.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and/or relevance regarding the scope of this review. Data</span></p>
<p style="top:507.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">extraction was performed by six authors (ML, BP, EC,</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">FML, JH, CP), using a standardized extraction form. This</span></p>
<p style="top:531.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tool assessed the study design, population (number of ani-</span></p>
<p style="top:543.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mals/participants, animal model/ageing individuals or AD</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">patients), type of ketogenic intervention, outcomes (e.g.</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">biological endpoint, clinical endpoint, neuroimaging end-</span></p>
<p style="top:579.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">point), follow-up duration, nutritional changes and poten-</span></p>
<p style="top:591.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tial side effects due to the intervention. This search was</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">carried out in April 2019.</span></p>
<p style="top:627.1pt;left:304.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Results</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Among one hundred forty-six selected papers, we identi-</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">fied 84 interventional studies. Two additional interven-</span></p>
<p style="top:663.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tional studies were found through the bibliography of the</span></p>
<p style="top:675.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">relevant animal studies papers. In total, 22 (11 animal</span></p>
<p style="top:687.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies and 11 human studies) were considered relevant</span></p>
<p style="top:699.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">for the present review. We summarized details of animal</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and human studies in Tables</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 1</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> and</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 2</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">, respectively. Figure</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 1</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">outlines the results of the systematic searches.</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 2 of 10</span></p>


<p style="top:459.1pt;left:56.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Preclinical studies</span></p>
<p style="top:471.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Two types of interventions were used: KD (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 7) either</span></p>
<p style="top:483.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ad libitum or calorie-controlled, and KS (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 4), com-</span></p>
<p style="top:495.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pared to control diet or placebo, respectively. Even if the</span></p>
<p style="top:507.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">total number of animals varied from one study to the</span></p>
<p style="top:519.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">other (from 16 to 65 with a mean of 48.5 &#xb1; 5.2 animals),</span></p>
<p style="top:531.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the number in each treatment group was nearly the</span></p>
<p style="top:543.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">same. Overall, baseline age at the start, species or AD</span></p>
<p style="top:555.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">model type, sex and follow-up duration varied between</span></p>
<p style="top:567.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies.</span></p>
<p style="top:592.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Ageing animals</span></p>
<p style="top:603.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Five studies assessed ketogenic interventions in ageing</span></p>
<p style="top:615.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">animals. The mean age at baseline varied depending on</span></p>
<p style="top:627.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the studied species: 9 years for beagle dogs (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 1), above</span></p>
<p style="top:639.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">20 months for wild-type (WT) rats (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 3) and 12</span></p>
<p style="top:651.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">months for WT mice (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 1). Only two studies out of</span></p>
<p style="top:663.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">five compared young (4-month-old WT rats) vs ageing</span></p>
<p style="top:675.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">animals [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 21</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Three studies used only ageing male</span></p>
<p style="top:687.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">rodents [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 27</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] whereas two other studies compared</span></p>
<p style="top:699.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the effect of KD/KS on ageing males and females [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">21</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:711.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. The follow-up duration was different according to</span></p>
<p style="top:723.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">species: 8 or 12 weeks for WT rats [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 21</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 27</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], 32 weeks</span></p>
<p style="top:459.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">for beagle dogs [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] and 72 weeks for old WT mice on</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">which the effect of KD on life span was evaluated [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:496.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Alzheimer</span><span style="font-family:QntkbsAdvTT99c4c969+20,serif;font-size:9.2pt;color:#131313">&#x2019;</span><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">s disease animal models</span></p>
<p style="top:507.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Six studies included different AD mouse models, based</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">on the amyloid cascade hypothesis. Briefly, 3xTgAD</span></p>
<p style="top:531.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mice [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 25</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], APP/PS1 mice [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 18</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], APP [V7171] mice</span></p>
<p style="top:543.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">[</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] and APP+PS1 [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] mice were used. Interestingly,</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Brownlow et al. choose to compare an amyloid-based</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">AD model (APP+PS1 mice) and a tau-based AD model</span></p>
<p style="top:579.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(Tg4510 AD mice) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. One of these studies used only</span></p>
<p style="top:591.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">female AD mouse model (APP [V7171]) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Regarding</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">baseline age, 3xTgAD mice were older (8.5 months) than</span></p>
<p style="top:615.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">APP [V7171] (3 months), APP/PS1 (between 1 and 3</span></p>
<p style="top:627.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">months) and APP+PS1 and Tg4510 mice (5 months).</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">The follow-up duration varied from 4 to 32 weeks (mean</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">17 &#xb1; 5.05 weeks) without a link between duration and a</span></p>
<p style="top:663.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">type of AD model.</span></p>
<p style="top:688.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Outcomes and results</span></p>
<p style="top:699.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">The following objectives were assessed: efficacy on cog-</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">nition and/or motor functions (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 3 assessing both,</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 5 assessing cognition only,</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313"> N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 1 assessing motor</span></p>
<p style="top:87.9pt;left:56.7pt;line-height:9.0pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:9.0pt;color:#131313">Table 1</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:9.0pt;color:#131313"> Animal studies discussed in the present review</span></p>
<p style="top:101.8pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Study 1st</span></p>
<p style="top:110.8pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">author (ref)</span></p>
<p style="top:101.8pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Models</span></p>
<p style="top:101.8pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Intervention</span></p>
<p style="top:101.8pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Number FU</span></p>
<p style="top:101.8pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Outcomes</span></p>
<p style="top:101.8pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Positive results</span></p>
<p style="top:110.8pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">(intervention group)</span></p>
<p style="top:101.8pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Nutritional changes</span></p>
<p style="top:110.8pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">(vs ctrl group)</span></p>
<p style="top:124.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Aso [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">17</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:124.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">APP/PS1 mice KD + triheptanoin</span></p>
<p style="top:133.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">vs KD</span></p>
<p style="top:124.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">28</span></p>
<p style="top:124.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:124.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, AD features</span></p>
<p style="top:133.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">inflammation markers</span></p>
<p style="top:124.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition and</span></p>
<p style="top:133.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">neuroinflammation</span></p>
<p style="top:124.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:147.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Beckett [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">18</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:147.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">APP/PS1 mice KD ad libitum</span></p>
<p style="top:147.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">65</span></p>
<p style="top:147.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">4</span></p>
<p style="top:147.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Motor functions, AD</span></p>
<p style="top:156.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">features, oxidative</span></p>
<p style="top:165.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">stress</span></p>
<p style="top:147.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Motor coordination (rotarod) Weight loss</span></p>
<p style="top:179.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Brownlow [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">19</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:179.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">APP/PS1 and</span></p>
<p style="top:188.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Tg4510 mice</span></p>
<p style="top:179.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KD ad libitum</span></p>
<p style="top:179.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">60</span></p>
<p style="top:179.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">16</span></p>
<p style="top:179.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, motor</span></p>
<p style="top:188.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">unctions, AD features</span></p>
<p style="top:179.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Motor coordination (rotarod) Stable weight</span></p>
<p style="top:202.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Hernandez [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">20</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:202.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Young vs old</span></p>
<p style="top:211.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">WT rats</span></p>
<p style="top:202.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KD cal ctrl</span></p>
<p style="top:202.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">56</span></p>
<p style="top:202.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:202.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Body composition,</span></p>
<p style="top:211.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">transporter expression</span></p>
<p style="top:202.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Less adipose tissues</span></p>
<p style="top:211.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">and reversed age-</span></p>
<p style="top:220.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">related transporters</span></p>
<p style="top:229.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">evolution</span></p>
<p style="top:202.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:243.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Hernandez [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">21</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:243.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Young vs old</span></p>
<p style="top:252.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">WT rats</span></p>
<p style="top:243.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KD cal ctrl</span></p>
<p style="top:243.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">39</span></p>
<p style="top:243.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:243.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, transporter</span></p>
<p style="top:252.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">expression</span></p>
<p style="top:243.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition and</span></p>
<p style="top:252.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">reversed age-related</span></p>
<p style="top:261.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">transporters evolution</span></p>
<p style="top:243.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss in</span></p>
<p style="top:252.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">old rats</span></p>
<p style="top:275.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Kashiwaya [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">22</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:275.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">3xTgAD mice</span></p>
<p style="top:275.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs CD</span></p>
<p style="top:275.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">30</span></p>
<p style="top:275.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">32</span></p>
<p style="top:275.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, AD features Cognition and AD</span></p>
<p style="top:284.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">features</span></p>
<p style="top:275.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss</span></p>
<p style="top:298.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Newman [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">23</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:298.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Young vs old</span></p>
<p style="top:307.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">WT mice</span></p>
<p style="top:298.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cyclic KD ad libitum 58</span></p>
<p style="top:298.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">72</span></p>
<p style="top:298.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, motor</span></p>
<p style="top:307.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">functions, health</span></p>
<p style="top:316.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">span, gene expression</span></p>
<p style="top:298.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition and</span></p>
<p style="top:307.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">reduced mid-life</span></p>
<p style="top:316.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">mortality</span></p>
<p style="top:298.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Stable weight</span></p>
<p style="top:330.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Pan [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">24</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:330.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Old beagle</span></p>
<p style="top:339.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">dogs</span></p>
<p style="top:330.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs CD</span></p>
<p style="top:330.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">24</span></p>
<p style="top:330.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">32</span></p>
<p style="top:330.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:330.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:330.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Stable weight</span></p>
<p style="top:353.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Pawlosky [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">25</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:353.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">3xTgAD mice</span></p>
<p style="top:353.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs CD</span></p>
<p style="top:353.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">24</span></p>
<p style="top:353.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">32</span></p>
<p style="top:353.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Metabolism, protein</span></p>
<p style="top:362.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">expression</span></p>
<p style="top:353.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Reduced protein</span></p>
<p style="top:362.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">oxidation and BACE</span></p>
<p style="top:371.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">1 expression</span></p>
<p style="top:353.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss</span></p>
<p style="top:385.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Van der Auwera [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">26</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:385.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">APP/V717I</span></p>
<p style="top:394.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">mice</span></p>
<p style="top:385.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KD ad libitum,</span></p>
<p style="top:394.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">crossover</span></p>
<p style="top:385.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">16</span></p>
<p style="top:385.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">6</span></p>
<p style="top:385.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, AD</span></p>
<p style="top:394.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">features</span></p>
<p style="top:385.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Reduced brain</span></p>
<p style="top:394.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">total A</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:8.0pt">&#x3b2;</span></p>
<p style="top:385.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss</span></p>
<p style="top:408.0pt;left:56.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Wang [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">27</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:408.0pt;left:128.6pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Old WT rats</span></p>
<p style="top:408.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS (MCT 8 or 10)</span></p>
<p style="top:417.0pt;left:179.7pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">vs CD</span></p>
<p style="top:408.0pt;left:250.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">36</span></p>
<p style="top:408.0pt;left:283.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">8</span></p>
<p style="top:408.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition, synapse</span></p>
<p style="top:417.0pt;left:298.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">pathway</span></p>
<p style="top:408.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition and</span></p>
<p style="top:417.0pt;left:377.5pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">synaptic stability</span></p>
<p style="top:408.0pt;left:476.2pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss</span></p>
<p style="top:430.9pt;left:56.7pt;line-height:7.0pt"><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt">A</span><span style="font-family:FlggdqAdvTT7329fd89.I+03,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> beta-amyloid peptide,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> AD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Alzheimer</span><span style="font-family:TdvqrrAdvTTe45e47d2+20,serif;font-size:7.0pt">&#x2019;</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt">s disease,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> BACE 1</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> beta-secretase 1,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> cal ctrl</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> calorie-controlled,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> CD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> control diet,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> ctrl</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> control,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> FU</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> follow-up duration (given in</span></p>
<p style="top:439.4pt;left:56.7pt;line-height:7.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt">weeks),</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> KD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> ketogenic diet,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> KS</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> ketone supplementation</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 3 of 10</span></p>


<p style="top:724.1pt;left:140.6pt;line-height:9.0pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:9.0pt;color:#131313">Table 2</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:9.0pt;color:#131313"> Human studies discussed in the present review</span></p>
<p style="top:724.9pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Study 1st</span></p>
<p style="top:724.9pt;left:163.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">author (ref)</span></p>
<p style="top:668.2pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Population</span></p>
<p style="top:583.3pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Mean age</span></p>
<p style="top:583.3pt;left:163.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">(SD)</span></p>
<p style="top:534.2pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Intervention</span></p>
<p style="top:467.6pt;left:155.0pt;line-height:8.0pt"><span style="font-family:MmddgvAdvTT1b53b5fb.I,serif;font-size:8.0pt">N</span></p>
<p style="top:448.5pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Design</span></p>
<p style="top:397.9pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">FU</span></p>
<p style="top:381.7pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Outcomes</span></p>
<p style="top:302.1pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Positive outcomes</span></p>
<p style="top:302.1pt;left:163.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">(intervention group)</span></p>
<p style="top:229.9pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Plasma KB</span></p>
<p style="top:229.9pt;left:163.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">levels</span></p>
<p style="top:186.8pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Nutritional</span></p>
<p style="top:186.8pt;left:163.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">changes</span></p>
<p style="top:119.9pt;left:154.9pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Side effects</span></p>
<p style="top:724.9pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Fortier [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">28</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MCI</span></p>
<p style="top:583.3pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">75.4 (6.6)</span></p>
<p style="top:534.2pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs placebo</span></p>
<p style="top:467.6pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">52</span></p>
<p style="top:448.5pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">26</span></p>
<p style="top:381.7pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MMSE, MoCa, brain</span></p>
<p style="top:381.7pt;left:186.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">PET imaging</span></p>
<p style="top:302.1pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Imaging (but not</span></p>
<p style="top:302.1pt;left:186.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">cognition)</span></p>
<p style="top:229.9pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Stable weight</span></p>
<p style="top:119.9pt;left:177.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No adverse</span></p>
<p style="top:119.9pt;left:186.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">effect</span></p>
<p style="top:724.9pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Ota [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">29</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Mild-moderate AD</span></p>
<p style="top:583.2pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">73.4 (6.0)</span></p>
<p style="top:534.1pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs control</span></p>
<p style="top:467.5pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">20</span></p>
<p style="top:448.5pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:381.6pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Memory, executive</span></p>
<p style="top:381.7pt;left:209.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">function</span></p>
<p style="top:302.1pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:200.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Torosyan [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">30</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Mild-moderate AD</span></p>
<p style="top:583.2pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">79.9 (9.2)</span></p>
<p style="top:534.2pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs control</span></p>
<p style="top:467.6pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">14</span></p>
<p style="top:448.5pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">6</span></p>
<p style="top:381.7pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Brain PET imaging</span></p>
<p style="top:302.1pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Imaging</span></p>
<p style="top:229.9pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No</span></p>
<p style="top:186.7pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:223.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Taylor [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">31</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MCI or AD dementia</span></p>
<p style="top:583.3pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">73.1 (9.0)</span></p>
<p style="top:534.2pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS</span></p>
<p style="top:467.6pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">15</span></p>
<p style="top:448.5pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No control</span></p>
<p style="top:448.5pt;left:246.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">group</span></p>
<p style="top:397.9pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:381.7pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">ADAS-cog, MMSE,</span></p>
<p style="top:381.7pt;left:246.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">feasibility</span></p>
<p style="top:302.1pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Stable weight,</span></p>
<p style="top:186.8pt;left:246.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">cholesterol,</span></p>
<p style="top:186.8pt;left:255.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">glucose</span></p>
<p style="top:119.9pt;left:237.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Abe [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">32</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Nursing home</span></p>
<p style="top:668.2pt;left:278.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">residents</span></p>
<p style="top:583.3pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">86.6 (4.8)</span></p>
<p style="top:534.2pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS + vitD + leucine</span></p>
<p style="top:534.2pt;left:278.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">vs vitD leucine vs</span></p>
<p style="top:534.2pt;left:287.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">control</span></p>
<p style="top:467.6pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">38</span></p>
<p style="top:448.5pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:381.7pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MMSE</span></p>
<p style="top:302.1pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No</span></p>
<p style="top:186.8pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Improved muscle</span></p>
<p style="top:186.8pt;left:278.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">mass and function</span></p>
<p style="top:119.9pt;left:269.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Ota [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">33</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">60+ adults no dementia</span></p>
<p style="top:583.3pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">66.1 (2.9)</span></p>
<p style="top:534.2pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs placebo</span></p>
<p style="top:467.6pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">19</span></p>
<p style="top:448.5pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Crossover, RC</span></p>
<p style="top:397.9pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">0</span></p>
<p style="top:381.7pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Memory, executive</span></p>
<p style="top:381.7pt;left:310.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">function</span></p>
<p style="top:302.1pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:301.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Ohnuma [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">34</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Mild moderate AD</span></p>
<p style="top:583.2pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">63.9 (8.5)</span></p>
<p style="top:534.1pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs control</span></p>
<p style="top:467.5pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">22</span></p>
<p style="top:448.5pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:381.7pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MMSE</span></p>
<p style="top:302.1pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">None</span></p>
<p style="top:229.9pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.7pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:324.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:724.9pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Rebello [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">35</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MCI</span></p>
<p style="top:583.3pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Not available</span></p>
<p style="top:534.1pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs control</span></p>
<p style="top:467.5pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">6</span></p>
<p style="top:448.5pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">24</span></p>
<p style="top:381.6pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">ADAS-cog,</span></p>
<p style="top:381.7pt;left:347.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">TMT, DST</span></p>
<p style="top:302.1pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Inconclusive</span></p>
<p style="top:229.9pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Stable weight</span></p>
<p style="top:119.9pt;left:338.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No adverse</span></p>
<p style="top:119.9pt;left:347.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">effect</span></p>
<p style="top:724.9pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Krikorian [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">36</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MCI</span></p>
<p style="top:583.3pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">70.1 (6.2)</span></p>
<p style="top:534.2pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KD vs CD</span></p>
<p style="top:467.6pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">23</span></p>
<p style="top:448.5pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">6</span></p>
<p style="top:381.7pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Executive function,</span></p>
<p style="top:381.7pt;left:370.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">memory</span></p>
<p style="top:302.1pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No (urinary</span></p>
<p style="top:229.9pt;left:370.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">tests)</span></p>
<p style="top:186.8pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Weight loss</span></p>
<p style="top:119.9pt;left:361.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">No adverse</span></p>
<p style="top:119.9pt;left:370.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">effect</span></p>
<p style="top:724.9pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Henderson [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">37</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Mild-moderate AD</span></p>
<p style="top:583.2pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">76.9 (7.9)</span></p>
<p style="top:534.1pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs placebo</span></p>
<p style="top:467.5pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">152</span></p>
<p style="top:448.5pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">RCT</span></p>
<p style="top:397.9pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">12</span></p>
<p style="top:381.6pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">ADAS-cog, ADCS-CGIC</span></p>
<p style="top:302.1pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:384.0pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Frequent GI</span></p>
<p style="top:119.9pt;left:393.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">symptoms</span></p>
<p style="top:724.9pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Reger [</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#0000ff">38</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">]</span></p>
<p style="top:668.2pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">MCI or AD dementia</span></p>
<p style="top:583.3pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">74.7 (6.7)</span></p>
<p style="top:534.2pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">KS vs placebo</span></p>
<p style="top:467.6pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">20</span></p>
<p style="top:448.5pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Crossover, RC</span></p>
<p style="top:397.9pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">0</span></p>
<p style="top:381.7pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">ADAS-cog, MMSE,</span></p>
<p style="top:381.7pt;left:416.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">word recall, Stroop</span></p>
<p style="top:302.1pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Cognition</span></p>
<p style="top:229.9pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Yes</span></p>
<p style="top:186.8pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:119.9pt;left:407.1pt;line-height:8.0pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt">Unassessed</span></p>
<p style="top:725.7pt;left:430.0pt;line-height:7.0pt"><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt">AD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Alzheimer</span><span style="font-family:TdvqrrAdvTTe45e47d2+20,serif;font-size:7.0pt">&#x2019;</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt">s disease,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> ADAS-cog</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Alzheimer Disease Assessment Scale,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> ADCS-CGIC</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Alzheimer</span><span style="font-family:TdvqrrAdvTTe45e47d2+20,serif;font-size:7.0pt">&#x2019;</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt">s Disease Cooperative Study Clinical Global Impression of Change,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> CD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> control diet,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> DST</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Digit Symbol Test,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> FU</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> follow-up</span></p>
<p style="top:725.7pt;left:438.5pt;line-height:7.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt">duration,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> GI</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> gastrointestinal,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> KB</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> ketone bodies,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> KD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> ketogenic diet,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> KS</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> ketone supplementation,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> MCI</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> mild cognitive impairment,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> MoCA</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Montreal Cognitive Assessment,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> N</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> number,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> MMSE</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Mini-Mental Status Examination,</span></p>
<p style="top:725.7pt;left:447.0pt;line-height:7.0pt"><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt">PET</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> positron emission tomography,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> RCT</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> randomized controlled trial,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> TMT</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> Trail Making Test,</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:7.0pt"> vitD</span><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.0pt"> vitamin D</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 4 of 10</span></p>


<p style="top:471.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">function only), impact on neuropathological AD lesions</span></p>
<p style="top:483.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 5), KD safety (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 1) and weight variations (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 9).</span></p>
<p style="top:495.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Eight studies (one in old WT mice, two in young vs age-</span></p>
<p style="top:507.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ing WT rats and five in AD mouse models) evaluated</span></p>
<p style="top:519.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">multiple outcomes.</span></p>
<p style="top:544.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">In ageing animals</span></p>
<p style="top:555.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Three studies evaluated the effects of KD in ageing ani-</span></p>
<p style="top:567.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mals, either on safety and cognition [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], weight and</span></p>
<p style="top:579.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">neurotransmitter function [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] or cognition/motor func-</span></p>
<p style="top:591.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tion and neurotransmitter function [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">21</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:616.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Effects of KD/KS on life expectancy and mortality</span></p>
<p style="top:627.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Only Newman et al. conducted a long-term study of KD.</span></p>
<p style="top:639.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">They showed that KD was able to reduce mid-life mor-</span></p>
<p style="top:651.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tality but without improving maximum lifespan in old</span></p>
<p style="top:663.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">C57Bl6 WT mice [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:688.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Cognitive and motor impact of KD/KS</span></p>
<p style="top:699.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Four studies evaluated the cognitive impact of KD and</span></p>
<p style="top:711.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">showed a positive effect on cognition, in ageing animals</span></p>
<p style="top:723.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">[</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 27</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. This effect was observed with several</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">KD formulae (two calorie-controlled KD, two KS). This result</span></p>
<p style="top:483.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">suggests that brain metabolism can shift towards the use of</span></p>
<p style="top:495.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">KB, regardless of the kind of ketone-oriented diet used,</span></p>
<p style="top:507.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with potential cognitive gain. Similarly, motor performances</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">were improved in all studies, regardless of potential associ-</span></p>
<p style="top:531.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ated cognitive benefits. These results are consistent with</span></p>
<p style="top:543.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">many mouse studies demonstrating that keto-adaptation</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">enhanced the capacity to transport and metabolize fat as</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">well as motor abilities and recovery [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">39</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2013;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">41</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:592.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Mechanisms underlying cognitive effects of KD and KS</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Hernandez et al. studied the effect of KD on transport</span></p>
<p style="top:615.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">protein expression in the brain of ageing mice, notably</span></p>
<p style="top:627.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">vesicular</span></p>
<p style="top:627.5pt;left:350.0pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">glutamate</span></p>
<p style="top:627.5pt;left:399.9pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and</span></p>
<p style="top:627.5pt;left:424.6pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">gamma-aminobutyric</span></p>
<p style="top:627.5pt;left:522.0pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">acid</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(GABA) transporters [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 21</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. They observed that KD ad</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">libitum was able to reverse the age-dependent decrease</span></p>
<p style="top:663.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of vesicular GABA transporter expression in the hippo-</span></p>
<p style="top:675.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">campus and in the prefrontal cortex. This result could</span></p>
<p style="top:687.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">be linked to the known effect of KD in epilepsy [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">3</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. In-</span></p>
<p style="top:699.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">deed, KD enhances GABA vesicular filling which main-</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tains</span></p>
<p style="top:711.5pt;left:333.6pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">an</span></p>
<p style="top:711.5pt;left:352.9pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">inhibitory</span></p>
<p style="top:711.5pt;left:402.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">feedback</span></p>
<p style="top:711.5pt;left:447.5pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">associated</span></p>
<p style="top:711.5pt;left:498.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with</span></p>
<p style="top:711.5pt;left:525.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">beneficial effect of KD. One can also hypothesize that</span></p>
<img style="position:absolute;transform:matrix(.31993435,0,-0,.3197984,-577.1093,-357.16065)" src="data:image/jpeg;base64,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">
<p style="top:441.5pt;left:62.7pt;line-height:8.0pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:8.0pt;color:#131313">Fig. 1</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:8.0pt;color:#131313"> Flow diagram of studies selection</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 5 of 10</span></p>


<p style="top:87.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">this effect on GABA may have a potential anxiolytic ef-</span></p>
<p style="top:99.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">fect. Interestingly, the authors described a similar rever-</span></p>
<p style="top:111.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">sal effect on the age-dependent decrease of vesicular</span></p>
<p style="top:123.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">glutamate transporter expression that was not restricted</span></p>
<p style="top:135.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to the hippocampus.</span></p>
<p style="top:147.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">In addition, Wang and Mitchell described that KS is</span></p>
<p style="top:159.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">associated, in old WT rats, with an increase in insulin</span></p>
<p style="top:171.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">receptor 1 levels and Akt phosphorylation and a de-</span></p>
<p style="top:183.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">crease in ribosomal protein S6 kinase phosphorylation</span></p>
<p style="top:195.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">[</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">27</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. KS effect on this pathway is associated with in-</span></p>
<p style="top:207.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">creased ube3a expression that notably plays a role in</span></p>
<p style="top:219.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">synaptic stabilization. Conversely, Newman et al. identi-</span></p>
<p style="top:231.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">fied a downregulation of the insulin pathway in old WT</span></p>
<p style="top:243.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mice fed with KD ad libitum [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. The conflicting results</span></p>
<p style="top:255.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of the two studies can be due to the discrepancies con-</span></p>
<p style="top:267.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cerning the duration of diet (8 vs 72 weeks) and/or the</span></p>
<p style="top:279.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">baseline age of the animals (21 vs 12 months). So far,</span></p>
<p style="top:291.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">data are not sufficient to conclude on the mechanisms</span></p>
<p style="top:303.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">responsible for the cognitive impact of KD/KS in ageing</span></p>
<p style="top:315.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">brain or whether there even is an impact. However, if</span></p>
<p style="top:327.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">there is an effect of KD/KS on cognition, one first hy-</span></p>
<p style="top:339.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pothesis might be synaptic protection through neuro-</span></p>
<p style="top:351.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">transmitter pathway and/or synaptic stabilizations.</span></p>
<p style="top:376.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Effects of KD/KS on weight</span></p>
<p style="top:387.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Two studies [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 27</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] showed a significant weight loss</span></p>
<p style="top:399.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">while no body weight modifications were observed in</span></p>
<p style="top:411.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the two others [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">23</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Among the four, only Hernan-</span></p>
<p style="top:423.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">dez et al. observed a significant weight loss despite a</span></p>
<p style="top:435.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">calorie-controlled KD. This effect was specific to old</span></p>
<p style="top:447.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">WT rats, but an unexpected fat mass reduction was ob-</span></p>
<p style="top:459.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">served both in young and old WT rats [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">20</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:484.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">In Alzheimer</span><span style="font-family:QntkbsAdvTT99c4c969+20,serif;font-size:9.2pt;color:#131313">&#x2019;</span><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">s disease animal models</span></p>
<p style="top:495.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">In details, five studies using AD mouse models assessed</span></p>
<p style="top:507.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cognition and/or motor function together with histo-</span></p>
<p style="top:519.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">logical data [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2013;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] while one assessed both im-</span></p>
<p style="top:531.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pacts on weight and histology [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:556.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Cognitive and motor impact of KD/KS</span></p>
<p style="top:567.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Two studies assessed the cognitive impact of KD in AD</span></p>
<p style="top:579.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mouse models [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Mice only showed a cognitive</span></p>
<p style="top:591.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">gain in the latter study, in which triheptanoin was added</span></p>
<p style="top:603.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to KD. According to the authors, the cognitive gain was</span></p>
<p style="top:615.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">likely to result from an enhanced mitochondrial func-</span></p>
<p style="top:627.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tion, due to triheptanoin supplementation [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. In the</span></p>
<p style="top:639.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">other study, motor coordination was significantly im-</span></p>
<p style="top:651.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">proved in the KD group.</span></p>
<p style="top:676.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Effects of KD/KS on AD pathological lesions</span></p>
<p style="top:687.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Five studies specifically assessed the changes in A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> and/</span></p>
<p style="top:699.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">or tau deposition in AD mouse models [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2013;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:711.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Kashiwaya et al. and Van der Auwera et al. described a</span></p>
<p style="top:723.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">decrease in A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> deposition in the brain of KD-fed female</span></p>
<p style="top:87.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">APP [V7171] and male 3xTgAD mice, respectively. In</span></p>
<p style="top:99.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">addition, Kashiwaya et al. reported a significant reduc-</span></p>
<p style="top:111.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tion of abnormal pTau labelling in the hippocampal neu-</span></p>
<p style="top:123.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">rons of 3xTgAD mice under a calorie-controlled KD. On</span></p>
<p style="top:135.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the other hand, Aso et al., Beckett et al. and Brownlow</span></p>
<p style="top:147.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">et al. failed to report any significant improvement in</span></p>
<p style="top:159.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">brain amyloid load after KD in APP/PS1 [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 18</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">],</span></p>
<p style="top:171.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">APP+PS1 and Tg4510 (tau) AD mouse models [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:183.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Several factors or combined factors could explain this</span></p>
<p style="top:195.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">discrepancy, but we will focus on the two mains: (i) type</span></p>
<p style="top:207.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of diet and/or its duration and (ii) type of AD model and</span></p>
<p style="top:219.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">time course of lesion onset. Regarding diet, the duration</span></p>
<p style="top:231.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of the intervention might have played a role in the ob-</span></p>
<p style="top:243.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">served discrepancy. Indeed, this effect on A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> accumula-</span></p>
<p style="top:255.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tion and pTau pathology in 3xTgAD mice was described</span></p>
<p style="top:267.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">when an animal received a KS for 32 weeks [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. This re-</span></p>
<p style="top:279.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">sult may also be due to a specific therapeutic effect of</span></p>
<p style="top:291.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the synthetic ketone ester (R)-3-hydroxybutyrate-(R)-1,</span></p>
<p style="top:303.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">3-butanediol</span></p>
<p style="top:303.5pt;left:365.2pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">monoester,</span></p>
<p style="top:303.5pt;left:419.2pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">administered</span></p>
<p style="top:303.5pt;left:480.9pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">as</span></p>
<p style="top:303.5pt;left:497.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">a</span></p>
<p style="top:303.5pt;left:510.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">dietary</span></p>
<p style="top:315.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">supplement.</span></p>
<p style="top:327.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">The choice of an AD mouse model is crucial in this</span></p>
<p style="top:339.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">setting. All AD mouse models used are based on the</span></p>
<p style="top:351.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">overexpression of A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">, but they differed in terms of the</span></p>
<p style="top:363.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">type and/or the pathological time course of the disease.</span></p>
<p style="top:375.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Thus, promoters regulating the mutated gene expression</span></p>
<p style="top:387.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">are model-dependent and so is A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> production and accu-</span></p>
<p style="top:399.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mulation. AD models with high A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> production and ac-</span></p>
<p style="top:411.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cumulation like 3xTgAD (combining amyloidopathy and</span></p>
<p style="top:423.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tauopathy) or APP [V7171] (early-onset familial AD)</span></p>
<p style="top:435.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">were the ones in which the effect of the ketogenic inter-</span></p>
<p style="top:447.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ventions</span></p>
<p style="top:447.5pt;left:347.2pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">was</span></p>
<p style="top:447.5pt;left:370.4pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">observed</span></p>
<p style="top:447.5pt;left:414.8pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">[</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:447.5pt;left:438.1pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:447.5pt;left:461.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">KD,</span></p>
<p style="top:447.5pt;left:485.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">like</span></p>
<p style="top:447.5pt;left:507.9pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">calorie-</span></p>
<p style="top:459.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">restricted diet, might induce insulin-degrading enzymes</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">directed against A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">42</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Accordingly, an effect on A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span></p>
<p style="top:483.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">accumulation based on degradation is easier to observe</span></p>
<p style="top:495.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in animals with higher A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> accumulation. In addition, the</span></p>
<p style="top:507.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">time course of the lesions depends on model types.</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Therefore, if the aim of the intervention is to evaluate</span></p>
<p style="top:531.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the effect on A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> load, the intervention has to take into</span></p>
<p style="top:543.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">account this parameter. For example, in APP/PS1 mice,</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">soluble A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> became detectable from 3 months onward</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and amyloid plaques appeared at 9 months. Studying the</span></p>
<p style="top:579.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">effect of KD/KS before those milestones or with an early</span></p>
<p style="top:591.4pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">endpoint may lead to the absence of observed effect [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">18</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. It is also interesting to note that the type of pro-</span></p>
<p style="top:615.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">moter also affects the magnitude of A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> load. For ex-</span></p>
<p style="top:627.4pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ample, the prion protein promoter, present in APP+PS1</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and APP/PS1, is responsible for a more widespread and</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">less</span></p>
<p style="top:651.5pt;left:330.6pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">selective</span></p>
<p style="top:651.5pt;left:376.0pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span></p>
<p style="top:651.5pt;left:399.4pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">expression</span></p>
<p style="top:651.5pt;left:453.9pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">than</span></p>
<p style="top:651.5pt;left:483.5pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">others</span></p>
<p style="top:651.5pt;left:520.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">[</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">43</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:663.4pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Localization of amyloid brain load may differ from one</span></p>
<p style="top:675.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">animal model to the other, and analyzing methods have</span></p>
<p style="top:687.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to be adapted. Thus, analysis restricted to specific brain</span></p>
<p style="top:699.4pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">regions (e.g. A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> immunochemical labelling in the pre-</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">frontal cortex or hippocampus [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">24</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]) seems to be more</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">efficient than global analysis (e.g. whole-brain enzyme-</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 6 of 10</span></p>


<p style="top:87.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">linked immunosorbent assay against total A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> and APP</span></p>
<p style="top:99.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">C-terminal [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">25</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]).</span></p>
<p style="top:111.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Regarding other abnormal features in models of AD,</span></p>
<p style="top:123.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Aso et al. showed a reduction of neuroinflammation</span></p>
<p style="top:135.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">after intake of KD + triheptanoin in APP/PS1 mouse that</span></p>
<p style="top:147.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">was not observed in APP/PS1 mouse fed with KD only</span></p>
<p style="top:159.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and thus might be specific to triheptanoin supplementa-</span></p>
<p style="top:171.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tion [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">17</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Pawlosky et al. observed that KS induced a re-</span></p>
<p style="top:183.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">duction of the free radical insult against hippocampal</span></p>
<p style="top:195.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">proteins and modified both</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313"> &#x3b1;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">- and</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313"> &#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">-secretase expres-</span></p>
<p style="top:207.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">sion levels (higher and lower respectively) in hippocam-</span></p>
<p style="top:219.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pal but not in cortical lysates [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">25</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. KS is able to reduce</span></p>
<p style="top:231.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the levels of hippocampal BACE 1, a key enzyme in the</span></p>
<p style="top:243.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">production of A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> peptide, and this finding could explain</span></p>
<p style="top:255.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the reduction of amyloid load.</span></p>
<p style="top:267.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Overall, KD and KS seemed to be able to reduce A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span></p>
<p style="top:279.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and pTau load as well as neuroinflammation, especially</span></p>
<p style="top:291.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in aggressive mouse models treated for a long time. In</span></p>
<p style="top:303.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">some models, those neuropathological effects were asso-</span></p>
<p style="top:315.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ciated with improvement of cognitive and/or motor</span></p>
<p style="top:327.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">functions. While the underlying mechanisms remain to</span></p>
<p style="top:339.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">be elucidated, these observations support the hypothesis</span></p>
<p style="top:351.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">that KD/KS might have definite therapeutic actions on</span></p>
<p style="top:363.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">AD abnormal biological pathways.</span></p>
<p style="top:388.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Effects of KD/KS on weight</span></p>
<p style="top:399.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Four studies, using various methodologies, observed a</span></p>
<p style="top:411.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">significant weight loss [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">18</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 22</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 25</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 26</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], while no body</span></p>
<p style="top:423.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">weight modifications were observed in the last one [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">19</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:435.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Thus, while these studies used variable material and ap-</span></p>
<p style="top:447.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">proaches, most of them found a reproducible weight loss</span></p>
<p style="top:459.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">induced by KD or KS. However, details are lacking to</span></p>
<p style="top:471.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">draw definite conclusions on the mechanisms of this</span></p>
<p style="top:483.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">weight loss and its consequences on the safety of this ap-</span></p>
<p style="top:495.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">proach. There was no reported association of weight loss</span></p>
<p style="top:507.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to cognitive change in these studies.</span></p>
<p style="top:531.1pt;left:56.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Clinical studies</span></p>
<p style="top:544.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">General characteristics of the studies</span></p>
<p style="top:555.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Included humans studies (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 11) are presented in</span></p>
<p style="top:567.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Table</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 2</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">. They involved either ageing subjects with or</span></p>
<p style="top:579.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">without mild cognitive impairment (MCI) (</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 6; mean</span></p>
<p style="top:591.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">age 66.1 to 75.4 years old; mean Mini-Mental Status</span></p>
<p style="top:603.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Examination (MMSE) score at baseline 17.1 to 27.1) or</span></p>
<p style="top:615.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">individuals with AD dementia based on clinical diagnos-</span></p>
<p style="top:627.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tic criteria such as the Diagnostic and Statistical Manual</span></p>
<p style="top:639.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of Mental Disorders-IV or the National Institute of</span></p>
<p style="top:651.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Neurological and Communicative Diseases and Stroke/</span></p>
<p style="top:663.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Alzheimer</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">s Disease and Related Disorders Association</span></p>
<p style="top:675.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">N</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> = 5). In addition, these studies comprised inconsistent</span></p>
<p style="top:687.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">sex ratios (30 to 66% of male). Five of them indicated an</span></p>
<p style="top:699.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">average level of education between 12.5 and 15.3, and</span></p>
<p style="top:711.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">only one provided information about the ethnic groups</span></p>
<p style="top:723.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of the study population (mostly Caucasians in 91%).</span></p>
<p style="top:87.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Thus, participants showed various degrees of cognitive</span></p>
<p style="top:99.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">performance among studies, from normal ageing people</span></p>
<p style="top:111.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to moderate dementia. Two studies did not specify the de-</span></p>
<p style="top:123.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">gree of cognitive impairment of their participants [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">33</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 36</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:135.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">One can notice that the use of A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> or tau biomarkers,</span></p>
<p style="top:147.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">highly recommended for increasing diagnostic accuracy,</span></p>
<p style="top:159.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">was not mentioned in these studies. APOE genotyping</span></p>
<p style="top:171.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">was performed in four studies only [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:183.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Regarding nutritional interventions, two studies used a</span></p>
<p style="top:195.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">classic KD approach while 11 relied on KS using MCT.</span></p>
<p style="top:207.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Of note, KS protocols differed much in composition and</span></p>
<p style="top:219.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">daily dose (20 to 56 g of MCT per day). Two studies had</span></p>
<p style="top:231.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">a crossover design [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">29</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] while one did not include a</span></p>
<p style="top:243.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">control group [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. The seven remaining studies were</span></p>
<p style="top:255.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">randomized controlled trials. The number of individuals</span></p>
<p style="top:267.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">included varied among studies from 6 to 152 (mean</span></p>
<p style="top:279.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">31.3 &#xb1; 38.2). Likewise, the follow-up durations were ra-</span></p>
<p style="top:291.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ther short and heterogeneous, from 0 to 26 weeks (mean</span></p>
<p style="top:303.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">11.2 &#xb1; 9) including three studies examining the immedi-</span></p>
<p style="top:315.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ate effect, the same day as the clinical and cognitive</span></p>
<p style="top:327.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">examination of KS [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:339.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">None of the studies included in this review provided</span></p>
<p style="top:351.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">details on patients</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> medical conditions. Apart from cog-</span></p>
<p style="top:363.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">nitive impairment, comorbidities are likely to modulate</span></p>
<p style="top:375.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the efficacy or the adhesion to KD or KS. For instance,</span></p>
<p style="top:387.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in patients with type 2 diabetes, very stringent KD may</span></p>
<p style="top:399.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">not be sustainable over long-term, although there is no</span></p>
<p style="top:411.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">formal contraindication to it [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">44</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Besides inflammatory</span></p>
<p style="top:423.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">diseases, mood disorders, chronic pain and polyphar-</span></p>
<p style="top:435.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">macy may change the nutritional status of the individ-</span></p>
<p style="top:447.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">uals, as well as the safety of a high-fat diet. Moreover,</span></p>
<p style="top:459.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">only Abe et al. presented its exclusion criteria: subjects</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with body mass index &lt; 23 kg/m</span><sup><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:6.9pt;color:#131313">2</span></sup><sup><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> </span></sup><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">or major organ dys-</span></p>
<p style="top:483.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">function [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">32</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Altogether, this impairs the external valid-</span></p>
<p style="top:495.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ity of the studies and pleads for new studies that would</span></p>
<p style="top:507.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">assess the interaction between comorbidities and KD/KS</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in patients.</span></p>
<p style="top:544.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Outcomes</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">All studies but one assessed cognitive changes after KS or</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">KD. One study focused on cognitive changes and the</span></p>
<p style="top:579.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">feasibility of long-term KS in cognitively impaired individ-</span></p>
<p style="top:591.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">uals [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">29</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. However, the instruments used to assess cogni-</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tive outcomes were inconsistent among studies. Five</span></p>
<p style="top:615.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies used the Mini-Mental Status Examination [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:627.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">32</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 34</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], and four of them utilized the Alzheimer Dis-</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ease Assessment Scale (ADAS-cog) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 35</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Two</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies used a neuroimaging (PET) endpoint: regional</span></p>
<p style="top:663.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cerebral blood flow [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">] or [11C]-acetoacetate tracer [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:688.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Metabolic effects of KD/KS in cognitively impaired patients</span></p>
<p style="top:700.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">and older adults</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Nine studies out of eleven monitored the plasma levels</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of KB to make sure that participants actually achieved</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 7 of 10</span></p>


<p style="top:87.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ketosis. Thus, the authors were able to demonstrate that</span></p>
<p style="top:99.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ketosis was quickly and efficiently reached in all the</span></p>
<p style="top:111.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies, regardless of the type of intervention. However,</span></p>
<p style="top:123.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">only five studies examined the changes in nutritional sta-</span></p>
<p style="top:135.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tus or body composition in patients under KS/KD [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:147.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 32</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 35</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 36</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Krikorian et al. highlighted a mean</span></p>
<p style="top:159.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">weight loss of 4 kg per individual after 6 weeks, in MCI</span></p>
<p style="top:171.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">adults under KD as compared to patients under control</span></p>
<p style="top:183.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">diet [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">36</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. This finding is consistent with the results of a</span></p>
<p style="top:195.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">meta-analysis showing that KD is commonly associated</span></p>
<p style="top:207.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with weight loss, due to reduced total calorie intake [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">45</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:219.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Three other studies did not show any significant</span></p>
<p style="top:231.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">weight change with KS [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 35</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Interestingly, Abe</span></p>
<p style="top:243.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">et al. observed that participants improved their muscle</span></p>
<p style="top:255.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mass and function [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">32</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Of note, those subjects received</span></p>
<p style="top:267.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">vitamin D and leucine in addition to the nutritional</span></p>
<p style="top:279.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">intervention, which may have contributed to this ana-</span></p>
<p style="top:291.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">bolic effect.</span></p>
<p style="top:303.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Finally, only four studies reported on the side effects</span></p>
<p style="top:315.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">of KS/KD [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 31</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 36</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], including the study by Hen-</span></p>
<p style="top:327.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">derson et al. that described gastrointestinal symptoms</span></p>
<p style="top:339.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(49%), which led to treatment discontinuation (23% in</span></p>
<p style="top:351.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the intervention group).</span></p>
<p style="top:387.0pt;left:56.7pt;line-height:9.2pt"><span style="font-family:MyhldvAdvTT83913201.I,serif;font-size:9.2pt;color:#131313">Cognitive effects of KD/KS</span></p>
<p style="top:398.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Apart from the Torosyan et al. study (no clinical end-</span></p>
<p style="top:410.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">point) [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">], the majority of the studies (six out of ten)</span></p>
<p style="top:422.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">observed</span></p>
<p style="top:422.5pt;left:100.8pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">significant</span></p>
<p style="top:422.5pt;left:150.5pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cognitive</span></p>
<p style="top:422.5pt;left:195.3pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">improvements</span></p>
<p style="top:422.5pt;left:261.8pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in</span></p>
<p style="top:422.5pt;left:277.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the</span></p>
<p style="top:434.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">intervention groups (KS or KD), regardless of partici-</span></p>
<p style="top:446.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pants</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> cognitive status (from MCI to severe AD pa-</span></p>
<p style="top:458.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tients). On the other hand, the three remaining studies</span></p>
<p style="top:470.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">did not report any significant effect on cognition [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 34</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span></p>
<p style="top:482.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">35</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Cunnane et al. previously mentioned that given a</span></p>
<p style="top:494.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">choice between glucose and ketones, neurons would ra-</span></p>
<p style="top:506.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ther consume the latter [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">8</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Besides, even though brain-</span></p>
<p style="top:518.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">imaging studies revealed that brain utilization of glucose</span></p>
<p style="top:530.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">declines in early AD, KB utilization does not [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">46</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. The</span></p>
<p style="top:542.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">results of the two PET imaging studies evaluated for this</span></p>
<p style="top:554.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">review were consistent with these findings [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">28</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:566.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Interestingly, Torosyan et al. showed a long-term in-</span></p>
<p style="top:578.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">crease in brain metabolism after KS in non-APOE4 indi-</span></p>
<p style="top:590.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">viduals [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. This is in line with the results of three</span></p>
<p style="top:602.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies included in this review that highlighted better ef-</span></p>
<p style="top:614.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ficiency of KS in non-APOE4 subjects [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">30</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">,</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff"> 38</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. There</span></p>
<p style="top:626.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">is also an established relationship between APOE4 geno-</span></p>
<p style="top:638.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">type and brain amyloid deposition. It is noteworthy to</span></p>
<p style="top:650.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">say that in the PREDIMED-NAVARRA randomized-</span></p>
<p style="top:662.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">controlled trial, non-APOE4 genotype was associated</span></p>
<p style="top:674.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with greater improvement of the MMSE and Clock</span></p>
<p style="top:686.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Drawing Test scores when following a Mediterranean</span></p>
<p style="top:698.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">diet rather than a Western-type diet [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">47</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Thus, the rela-</span></p>
<p style="top:710.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tionship between APOE4 status and cognitive effects of</span></p>
<p style="top:722.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">metabolic interventions deserves further investigations.</span></p>
<p style="top:88.0pt;left:304.7pt;line-height:9.2pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:9.2pt;color:#131313">Limitations of the studies</span></p>
<p style="top:99.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Despite the interesting findings of these 13 studies, many</span></p>
<p style="top:111.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">limitations must be acknowledged. First, studies appear</span></p>
<p style="top:123.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">highly heterogeneous, in particular regarding age, gender</span></p>
<p style="top:135.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ratios or participants</span><span style="font-family:VtcbxrAdvTT86d47313+20,serif;font-size:9.8pt;color:#131313">&#x2019;</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313"> cognitive status, which all have a</span></p>
<p style="top:147.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">significant effect on the risk of subsequent cognitive de-</span></p>
<p style="top:159.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cline. These limitations prevent from drawing robust</span></p>
<p style="top:171.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">conclusions about the cognitive benefits of the ketogenic</span></p>
<p style="top:183.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">interventions. Some results may also be questionable</span></p>
<p style="top:195.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">such as an unexpected cognitive decline measured with</span></p>
<p style="top:207.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the ADAS-cog scale under placebo after only 45 days in</span></p>
<p style="top:219.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">MCI individuals whereas in the intervention group, par-</span></p>
<p style="top:231.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ticipants maintained their cognitive level [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">37</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">].</span></p>
<p style="top:243.5pt;left:312.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">The short follow-up durations and the repeated cogni-</span></p>
<p style="top:255.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tive assessments are likely to be responsible for a retest</span></p>
<p style="top:267.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">effect especially in cognitively intact or MCI individuals.</span></p>
<p style="top:279.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Conversely, patients with mild-to-moderate dementia</span></p>
<p style="top:291.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">may be too severely impaired to observe benefits from</span></p>
<p style="top:303.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">an intervention. This observation was previously raised</span></p>
<p style="top:315.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">when discussing the failure of anti-amyloid therapies in</span></p>
<p style="top:327.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">AD [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">48</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Furthermore, all studies aimed at measuring</span></p>
<p style="top:339.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">short-term changes in cognition or brain metabolism.</span></p>
<p style="top:351.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">The absence of long-term follow-up did not provide any</span></p>
<p style="top:363.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">insight into the persistence of cognitive changes after</span></p>
<p style="top:375.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">discontinuation of the nutritional intervention. Adhesion</span></p>
<p style="top:387.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">to the KD or to KS intake must be carefully examined as</span></p>
<p style="top:399.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">far as long-term nutritional changes are expected. Be-</span></p>
<p style="top:411.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">sides, the monitoring of potential adverse effects is</span></p>
<p style="top:423.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mandatory, especially in AD, since nutritional status is a</span></p>
<p style="top:435.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">key predictor of rapid cognitive decline as well as func-</span></p>
<p style="top:447.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tional limitations [</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#0000ff">49</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">]. Finally, the small number of stud-</span></p>
<p style="top:459.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ies published so far raises the issue of a potential</span></p>
<p style="top:471.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">publication bias as negative studies on the effects of KS</span></p>
<p style="top:483.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">or KD on cognition could not be published.</span></p>
<p style="top:507.1pt;left:304.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Conclusion</span></p>
<p style="top:519.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">Despite the growing interest for KD in AD over the last</span></p>
<p style="top:531.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">years, only few interventional studies in animals or</span></p>
<p style="top:543.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">humans clearly addressed the subject. In preclinical</span></p>
<p style="top:555.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">studies, this review pointed out some interesting results</span></p>
<p style="top:567.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">such as improvement of cognition and motor function</span></p>
<p style="top:579.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">in some AD mouse model or ageing animals. The mech-</span></p>
<p style="top:591.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">anisms leading to a benefic effect on cognition could be</span></p>
<p style="top:603.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">due to the (i) modification in neurotransmitter transport</span></p>
<p style="top:615.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">pathway and/or synaptic maintenance in ageing WT ani-</span></p>
<p style="top:627.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">mals and (ii) improvement of abnormal features (A</span><span style="font-family:GksrsxAdvTT86d47313+03,serif;font-size:9.8pt;color:#131313">&#x3b2;</span></p>
<p style="top:639.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">load or neuroinflammation) in AD mouse models. How-</span></p>
<p style="top:651.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ever, we must keep in mind that KD was initially created</span></p>
<p style="top:663.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">(and is still popular) for inducing weight loss in healthy</span></p>
<p style="top:675.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">or overweighed adults. In cognitively impaired subjects,</span></p>
<p style="top:687.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">older adults or animal studies, it was also often associ-</span></p>
<p style="top:699.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ated with a significant weight loss. This consequence</span></p>
<p style="top:711.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">could play an adverse effect on muscle performance (sar-</span></p>
<p style="top:723.5pt;left:304.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">copenia) or even on cognitive decline. In humans,</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 8 of 10</span></p>


<p style="top:87.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">notwithstanding the high heterogeneity of the studies</span></p>
<p style="top:99.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">and methodological issues discussed above, most of the</span></p>
<p style="top:111.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">published studies could suggest improved cognitive out-</span></p>
<p style="top:123.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">comes (memory, executive function or global cognition)</span></p>
<p style="top:135.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with KS or KD, regardless of the severity of cognitive</span></p>
<p style="top:147.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">impairment. Both interventions seemed acceptable for</span></p>
<p style="top:159.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">included subjects and show efficacy to achieve ketosis.</span></p>
<p style="top:171.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">KD and KS intake both offer different features and po-</span></p>
<p style="top:183.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tential benefits. They also present different disadvan-</span></p>
<p style="top:195.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tages. KD might be difficult to start in older adults with</span></p>
<p style="top:207.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">modern eating habits and even more difficult to main-</span></p>
<p style="top:219.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">tain. KS are useful to achieve ketosis but do not lead to</span></p>
<p style="top:231.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">the same metabolic shift, since the brain is still being</span></p>
<p style="top:243.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">fueled by glucose.</span></p>
<p style="top:255.5pt;left:64.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">As a conclusion, the KD might be a promising way to</span></p>
<p style="top:267.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">fight against the cognitive symptoms of AD, especially</span></p>
<p style="top:279.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">from the prodromal stage of the disease (MCI). Regard-</span></p>
<p style="top:291.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ing the body of evidence discussed above, the hypothesis</span></p>
<p style="top:303.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">that KD could postpone cognitive decline in AD should</span></p>
<p style="top:315.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">be explored. Unlike omega-3 supplements or</span><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313"> Ginkgo</span></p>
<p style="top:327.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:TychjhAdvTT8861b38f.I,serif;font-size:9.8pt;color:#131313">biloba</span><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">, the ketogenic interventions have not been evalu-</span></p>
<p style="top:339.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">ated yet in large sample randomized controlled trials</span></p>
<p style="top:351.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">with sufficient follow-up and structured cognitive and</span></p>
<p style="top:363.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">neuroimaging outcomes. Therefore, further studies are</span></p>
<p style="top:375.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">warranted, in particular, in adults with early AD, not</span></p>
<p style="top:387.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">only to assess the efficiency of the KD on cognitive de-</span></p>
<p style="top:399.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">cline, but also to examine the adverse effects (e.g. weight</span></p>
<p style="top:411.5pt;left:56.7pt;line-height:9.8pt"><span style="font-family:XshgtnAdvTT86d47313,serif;font-size:9.8pt;color:#131313">loss, malnutrition) as well as the adherence to the diet.</span></p>
<p style="top:433.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Abbreviations</span></p>
<p style="top:442.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">A</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:7.5pt">&#x3b2;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">:</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:7.5pt;color:#131313"> &#x3b2;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">-Amyloid peptide; AD: Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.5pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">s disease; ADAS-cog: Alzheimer</span></p>
<p style="top:451.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Disease Assessment; ADCS-CGIC: Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.5pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">s Disease Cooperative Study</span></p>
<p style="top:460.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Scale Clinical Global Impression of Change; APOE4: Apolipoprotein E allele 4;</span></p>
<p style="top:469.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">APP: Amyloid precursor protein; BACE 1: Beta-secretase 1; cal ctrl: Calorie-</span></p>
<p style="top:478.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">controlled; CD: Control diet; DST: Digit Symbol Test; FDG: Flurodeoxyglucose;</span></p>
<p style="top:487.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">FU: Follow-up; GABA: Gamma-aminobutyric acid; GI: Gastro-intestinal;</span></p>
<p style="top:496.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">KB: Ketone bodies; KD: Ketogenic diet; KS: Ketone supplementation; MCI: Mild</span></p>
<p style="top:505.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">cognitive impairment; MCT: Medium-chain triglyceride; MeSH: Medical</span></p>
<p style="top:514.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">subject heading; MMSE: Mini-Mental Status Examination; MoCA: Montreal</span></p>
<p style="top:523.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Cognitive Assessment; PET: Positron emission tomography; PS: Presenilin;</span></p>
<p style="top:532.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">pTau: Phosphorylated tau; RCT: Randomized controlled trial; TMT: Trail</span></p>
<p style="top:541.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Making Test; vitD: Vitamin D; WT: Wild-type</span></p>
<p style="top:562.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Acknowledgements</span></p>
<p style="top:571.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Not applicable.</span></p>
<p style="top:591.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Authors</span><span style="font-family:QntkbsAdvTT99c4c969+20,serif;font-size:7.5pt;color:#131313">&#x2019;</span><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313"> contributions</span></p>
<p style="top:600.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">ML and BP analysed and interpreted the data and drafted the manuscript.</span></p>
<p style="top:609.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">EC, JH and FML critically reviewed the selected studies and revised the</span></p>
<p style="top:618.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">manuscript accordingly. CP conceived the original idea, reviewed the</span></p>
<p style="top:627.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">selected studies and revised the final version of the manuscript. All authors</span></p>
<p style="top:636.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">read and approved the submitted version.</span></p>
<p style="top:657.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Funding</span></p>
<p style="top:666.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Not applicable.</span></p>
<p style="top:686.8pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Availability of data and materials</span></p>
<p style="top:695.9pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Not applicable.</span></p>
<p style="top:716.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Ethics approval and consent to participate</span></p>
<p style="top:725.3pt;left:56.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Not applicable.</span></p>
<p style="top:89.4pt;left:304.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Consent for publication</span></p>
<p style="top:98.3pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Not applicable.</span></p>
<p style="top:123.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Competing interests</span></p>
<p style="top:132.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">The authors declare that they have no competing interests.</span></p>
<p style="top:150.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">Author details</span></p>
<p style="top:158.2pt;left:304.7pt;line-height:5.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt">1</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">INSERM U1144 Optimisation Th&#xe9;rapeutique en Neuropsychopharmacologie,</span></p>
<p style="top:168.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Universit&#xe9; de Paris, Paris, France.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt"> </span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt">2</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Centre de Neurologie Cognitive/CMRR</span></p>
<p style="top:177.9pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Paris Nord Ile de France, APHP Nord Universit&#xe9; de Paris, Lariboisi&#xe8;re Hospital</span></p>
<p style="top:186.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">200, rue du Faubourg Saint Denis, 75010 Paris, France.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt"> </span><sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.3pt">3</span></sup><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Department of</span></p>
<p style="top:195.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">Geriatrics, Bichat and Bretonneau Hospitals, APHP Nord Universit&#xe9; de Paris,</span></p>
<p style="top:204.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt">75018 Paris, France.</span></p>
<p style="top:222.8pt;left:304.7pt;line-height:7.5pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:7.5pt;color:#131313">Received: 7 January 2020 Accepted: 2 April 2020</span></p>
<img style="position:absolute;transform:matrix(.15999878,0,-0,.16000001,-55.701967,269.62675)" src="data:image/png;base64,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">
<p style="top:266.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">1.</span><sup><span style="font-family:PxfdbsAdvTT99c4c969,serif;font-size:7.5pt;color:#131313">References</span></sup></p>
<p style="top:266.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Boison D. New insights into the mechanisms of the ketogenic diet. Curr</span></p>
<p style="top:275.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Opin Neurol. 2017;30:187</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">92.</span></p>
<p style="top:284.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2.</span></p>
<p style="top:284.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Vidali S, Aminzadeh S, Lambert B, Rutherford T, Sperl W, Kofler B, et al.</span></p>
<p style="top:293.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Mitochondria: the ketogenic diet--a metabolism-based therapy. Int J</span></p>
<p style="top:302.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Biochem Cell Biol. 2015;63:55</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">9.</span></p>
<p style="top:311.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">3.</span></p>
<p style="top:311.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic</span></p>
<p style="top:320.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018;11:</span></p>
<p style="top:329.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">CD001903.</span></p>
<p style="top:338.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">4.</span></p>
<p style="top:338.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Di Lorenzo C, Coppola G, Di Lenola D, Evangelista M, Sirianni G, Rossi P,</span></p>
<p style="top:347.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">et al. Efficacy of modified Atkins ketogenic diet in chronic cluster headache:</span></p>
<p style="top:356.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">an open-label, single-arm, clinical trial. Front Neurol. 2018;9:64.</span></p>
<p style="top:365.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">5.</span></p>
<p style="top:365.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin</span></p>
<p style="top:374.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">resistance is associated with the pathology of Alzheimer disease: the</span></p>
<p style="top:383.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Hisayama Study. Neurology. 2010;75:764</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">70.</span></p>
<p style="top:392.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">6.</span></p>
<p style="top:392.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene</span></p>
<p style="top:401.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">polymorphism and risk of type 2 diabetes and cardiovascular disease.</span></p>
<p style="top:410.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Cardiovasc Diabetol. 2016;15:12.</span></p>
<p style="top:419.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">7.</span></p>
<p style="top:419.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Swerdlow RH. Mitochondria and cell bioenergetics: increasingly recognized</span></p>
<p style="top:428.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">components and a possible etiologic cause of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Antioxid</span></p>
<p style="top:437.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Redox Signal. 2012;16:1434</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">55.</span></p>
<p style="top:446.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">8.</span></p>
<p style="top:446.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M,</span></p>
<p style="top:455.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Hennebelle M, et al. Can ketones help rescue brain fuel supply in later life?</span></p>
<p style="top:464.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Implications for cognitive health during aging and the treatment of</span></p>
<p style="top:473.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Front Mol Neurosci. 2016;9:53.</span></p>
<p style="top:482.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">9.</span></p>
<p style="top:482.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Noh HS, Hah Y-S, Nilufar R, Han J, Bong J-H, Kang SS, et al. Acetoacetate</span></p>
<p style="top:491.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res.</span></p>
<p style="top:500.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2006;83:702</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">9.</span></p>
<p style="top:509.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">10.</span></p>
<p style="top:509.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al.</span></p>
<p style="top:518.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic</span></p>
<p style="top:527.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">diet. Ann Neurol. 2006;60:223</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">35.</span></p>
<p style="top:536.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">11.</span></p>
<p style="top:536.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Masino SA, Kawamura M, Wasser CD, Wasser CA, Pomeroy LT, Ruskin DN.</span></p>
<p style="top:545.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Adenosine, ketogenic diet and epilepsy: the emerging therapeutic</span></p>
<p style="top:554.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">relationship between metabolism and brain activity. Curr Neuropharmacol.</span></p>
<p style="top:563.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2009;7:257</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">68.</span></p>
<p style="top:572.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">12.</span></p>
<p style="top:572.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:5.5pt;color:#131313"> D</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">-</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:7.3pt;color:#131313">&#x3b2;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">-</span></p>
<p style="top:581.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">hydroxybutyrate protects neurons in models of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s and Parkinson</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s</span></p>
<p style="top:590.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">disease. Proc Natl Acad Sci U S A. 2000;97:5440</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">4.</span></p>
<p style="top:599.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">13.</span></p>
<p style="top:599.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Jeong EA, Jeon BT, Shin HJ, Kim N, Lee DH, Kim HJ, et al. Ketogenic diet-</span></p>
<p style="top:608.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">induced peroxisome proliferator-activated receptor-</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:7.3pt;color:#131313">&#x3b3;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313"> activation decreases</span></p>
<p style="top:617.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">neuroinflammation in the mouse hippocampus after kainic acid-induced</span></p>
<p style="top:626.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">seizures. Exp Neurol. 2011;232:195</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">202.</span></p>
<p style="top:635.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">14.</span></p>
<p style="top:635.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Broom GM, Shaw IC, Rucklidge JJ. The ketogenic diet as a potential</span></p>
<p style="top:644.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">treatment and prevention strategy for Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Nutr Burbank Los</span></p>
<p style="top:653.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Angel Cty Calif. 2019;60:118</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">21.</span></p>
<p style="top:662.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">15.</span></p>
<p style="top:662.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">W</span><span style="font-family:GrklhbAdvTTb5929f4c+01,serif;font-size:7.3pt;color:#131313">&#x142;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">odarek D. Role of ketogenic diets in neurodegenerative diseases</span></p>
<p style="top:671.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">(Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease and Parkinson</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease). Nutrients. 2019;11.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff"> https://doi.</span></p>
<p style="top:680.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff">org/10.3390/nu11010169</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">.</span></p>
<p style="top:689.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">16.</span></p>
<p style="top:689.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred</span></p>
<p style="top:698.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA</span></p>
<p style="top:707.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">statement. PLoS Med. 2009;6:e1000097.</span></p>
<p style="top:716.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">17.</span></p>
<p style="top:716.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Aso E, Semakova J, Joda L, Semak V, Halbaut L, Calpena A, et al.</span></p>
<p style="top:725.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Triheptanoin supplementation to ketogenic diet curbs cognitive</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:496.1pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 9 of 10</span></p>


<p style="top:89.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">impairment in APP/PS1 mice used as a model of familial Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s</span></p>
<p style="top:98.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">disease. Curr Alzheimer Res. 2013;10:290</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">7.</span></p>
<p style="top:107.8pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">18.</span></p>
<p style="top:107.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Beckett TL, Studzinski CM, Keller JN, Paul Murphy M, Niedowicz DM. A</span></p>
<p style="top:116.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketogenic diet improves motor performance but does not affect</span><span style="font-family:KhfcnjAdvTTb5929f4c+03,serif;font-size:7.3pt;color:#131313"> &#x3b2;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">-amyloid</span></p>
<p style="top:125.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">levels in a mouse model of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Brain Res. 2013;1505:61</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">7.</span></p>
<p style="top:135.1pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">19.</span></p>
<p style="top:135.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Brownlow ML, Benner L, D</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Agostino D, Gordon MN, Morgan D. Ketogenic</span></p>
<p style="top:144.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">diet improves motor performance but not cognition in two mouse models</span></p>
<p style="top:153.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s pathology. PLoS One. 2013;8:e75713.</span></p>
<p style="top:162.4pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">20.</span></p>
<p style="top:162.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Hernandez AR, Hernandez CM, Campos KT, Truckenbrod LM, Sakarya Y,</span></p>
<p style="top:171.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">McQuail JA, et al. The antiepileptic ketogenic diet alters hippocampal</span></p>
<p style="top:180.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">transporter levels and reduces adiposity in aged rats. J Gerontol A Biol Sci</span></p>
<p style="top:189.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Med Sci. 2018;73:450</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">8.</span></p>
<p style="top:198.7pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">21.</span></p>
<p style="top:198.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Hernandez AR, Hernandez CM, Campos K, Truckenbrod L, Federico Q, Moon</span></p>
<p style="top:207.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">B, et al. A ketogenic diet improves cognition and has biochemical effects in</span></p>
<p style="top:216.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">prefrontal cortex that are dissociable from hippocampus. Front Aging</span></p>
<p style="top:225.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Neurosci. 2018;10:391.</span></p>
<p style="top:235.0pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">22.</span></p>
<p style="top:235.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Kashiwaya Y, Bergman C, Lee J-H, Wan R, King MT, Mughal MR, et al. A</span></p>
<p style="top:244.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketone ester diet exhibits anxiolytic and cognition-sparing properties, and</span></p>
<p style="top:253.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">lessens amyloid and tau pathologies in a mouse model of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s</span></p>
<p style="top:262.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">disease. Neurobiol Aging. 2013;34:1530</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">9.</span></p>
<p style="top:271.3pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">23.</span></p>
<p style="top:271.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Newman JC, Covarrubias AJ, Zhao M, Yu X, Gut P, Ng C-P, et al. Ketogenic</span></p>
<p style="top:280.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">diet reduces midlife mortality and improves memory in aging mice. Cell</span></p>
<p style="top:289.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Metab. 2017;26:547</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">57 e8.</span></p>
<p style="top:298.6pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">24.</span></p>
<p style="top:298.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Pan Y, Larson B, Araujo JA, Lau W, de Rivera C, Santana R, et al. Dietary</span></p>
<p style="top:307.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">supplementation with medium-chain TAG has long-lasting cognition-</span></p>
<p style="top:316.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">enhancing effects in aged dogs. Br J Nutr. 2010;103:1746</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">54.</span></p>
<p style="top:325.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">25.</span></p>
<p style="top:325.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Pawlosky RJ, Kemper MF, Kashiwaya Y, King MT, Mattson MP, Veech RL.</span></p>
<p style="top:334.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic</span></p>
<p style="top:343.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">acid cycle intermediates and amino acids in a 3xTgAD mouse model of</span></p>
<p style="top:352.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. J Neurochem. 2017;141:195</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">207.</span></p>
<p style="top:362.2pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">26.</span></p>
<p style="top:362.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet</span></p>
<p style="top:371.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">reduces amyloid beta 40 and 42 in a mouse model of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease.</span></p>
<p style="top:380.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Nutr Metab. 2005;2:28.</span></p>
<p style="top:389.5pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">27.</span></p>
<p style="top:389.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Wang D, Mitchell ES. Cognition and synaptic-plasticity related changes in</span></p>
<p style="top:398.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">aged rats supplemented with 8- and 10-carbon medium chain triglycerides.</span></p>
<p style="top:407.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">PLoS One. 2016;11:e0160159.</span></p>
<p style="top:416.8pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">28.</span></p>
<p style="top:416.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Fortier M, Castellano C-A, Croteau E, Langlois F, Bocti C, St-Pierre V, et al. A</span></p>
<p style="top:425.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketogenic drink improves brain energy and some measures of cognition in</span></p>
<p style="top:434.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">mild cognitive impairment. Alzheimers Dement J Alzheimers Assoc. 2019;15:</span></p>
<p style="top:443.8pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">625</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">34.</span></p>
<p style="top:453.1pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">29.</span></p>
<p style="top:453.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Ota M, Matsuo J, Ishida I, Takano H, Yokoi Y, Hori H, et al. Effects of a</span></p>
<p style="top:462.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">medium-chain triglyceride-based ketogenic formula on cognitive function</span></p>
<p style="top:471.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">in patients with mild-to-moderate Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Neurosci Lett. 2019</span></p>
<p style="top:480.1pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Jan 18;690:232</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">6.</span></p>
<p style="top:489.4pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">30.</span></p>
<p style="top:489.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, et al.</span></p>
<p style="top:498.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Changes in regional cerebral blood flow associated with a 45 day course of</span></p>
<p style="top:507.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">the ketogenic agent, caprylidene, in patients with mild to moderate</span></p>
<p style="top:516.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease: results of a randomized, double-blinded, pilot study.</span></p>
<p style="top:525.4pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Exp Gerontol. 2018;111:118</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">21.</span></p>
<p style="top:534.7pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">31.</span></p>
<p style="top:534.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and</span></p>
<p style="top:543.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">efficacy data from a ketogenic diet intervention in Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease.</span></p>
<p style="top:552.7pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Alzheimers Dement N Y N. 2018;4:28</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">36.</span></p>
<p style="top:562.0pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">32.</span></p>
<p style="top:562.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Abe S, Ezaki O, Suzuki M. Medium-chain triglycerides in combination with</span></p>
<p style="top:571.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">leucine and vitamin D benefit cognition in frail elderly adults: a randomized</span></p>
<p style="top:580.0pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">controlled trial. J Nutr Sci Vitaminol (Tokyo). 2017;63:133</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">40.</span></p>
<p style="top:589.3pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">33.</span></p>
<p style="top:589.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Ota M, Matsuo J, Ishida I, Hattori K, Teraishi T, Tonouchi H, et al. Effect of a</span></p>
<p style="top:598.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketogenic meal on cognitive function in elderly adults: potential for</span></p>
<p style="top:607.3pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">cognitive enhancement. Psychopharmacology. 2016;233:3797</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">802.</span></p>
<p style="top:616.6pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">34.</span></p>
<p style="top:616.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Ohnuma T, Toda A, Kimoto A, Takebayashi Y, Higashiyama R, Tagata Y, et al.</span></p>
<p style="top:625.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Benefits of use, and tolerance of, medium-chain triglyceride medical food in</span></p>
<p style="top:634.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">the management of Japanese patients with Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease: a</span></p>
<p style="top:643.6pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">prospective, open-label pilot study. Clin Interv Aging. 2016;11:29</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">36.</span></p>
<p style="top:652.9pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">35.</span></p>
<p style="top:652.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Rebello CJ, Keller JN, Liu AG, Johnson WD, Greenway FL. Pilot feasibility and</span></p>
<p style="top:661.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">safety study examining the effect of medium chain triglyceride</span></p>
<p style="top:670.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">supplementation in subjects with mild cognitive impairment: a randomized</span></p>
<p style="top:679.9pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">controlled trial. BBA Clin. 2015;3:123</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">5.</span></p>
<p style="top:689.2pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">36.</span></p>
<p style="top:689.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary</span></p>
<p style="top:698.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketosis enhances memory in mild cognitive impairment. Neurobiol Aging.</span></p>
<p style="top:707.2pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2012;33:425 e19</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">27.</span></p>
<p style="top:716.5pt;left:56.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">37.</span></p>
<p style="top:716.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of</span></p>
<p style="top:725.5pt;left:71.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">the ketogenic agent AC-1202 in mild to moderate Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease: a</span></p>
<p style="top:89.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab.</span></p>
<p style="top:98.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2009;6:31.</span></p>
<p style="top:107.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">38.</span></p>
<p style="top:107.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al.</span></p>
<p style="top:116.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.</span></p>
<p style="top:125.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Neurobiol Aging. 2004;25:311</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">4.</span></p>
<p style="top:134.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">39.</span></p>
<p style="top:134.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Huang Q, Ma S, Tominaga T, Suzuki K, Liu C. An 8-week, low carbohydrate,</span></p>
<p style="top:143.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">high fat, ketogenic diet enhanced exhaustive exercise capacity in mice part</span></p>
<p style="top:152.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2: effect on fatigue recovery, post-exercise biomarkers and anti-oxidation</span></p>
<p style="top:161.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">capacity. Nutrients. 2018;10.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff"> https://doi.org/10.3390/nu10101339</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">.</span></p>
<p style="top:170.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">40.</span></p>
<p style="top:170.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Ma S, Huang Q, Tominaga T, Liu C, Suzuki K. An 8-week ketogenic</span></p>
<p style="top:179.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">diet alternated interleukin-6, ketolytic and lipolytic gene expression, and</span></p>
<p style="top:188.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">enhanced exercise capacity in mice. Nutrients. 2018;10.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff"> https://doi.org/10.</span></p>
<p style="top:197.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff">3390/nu10111696</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">.</span></p>
<p style="top:206.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">41.</span></p>
<p style="top:206.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Ma S, Huang Q, Yada K, Liu C, Suzuki K. An 8-week ketogenic low</span></p>
<p style="top:215.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">carbohydrate, high fat diet enhanced exhaustive exercise capacity in mice.</span></p>
<p style="top:224.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Nutrients. 2018;10.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff"> https://doi.org/10.3390/nu10060673</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">.</span></p>
<p style="top:233.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">42.</span></p>
<p style="top:233.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, et al. Caloric restriction</span></p>
<p style="top:242.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">attenuates beta-amyloid neuropathology in a mouse model of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s</span></p>
<p style="top:251.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">disease. FASEB J Off Publ Fed Am Soc Exp Biol. 2005;19:659</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">61.</span></p>
<p style="top:260.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">43.</span></p>
<p style="top:260.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Hall AM, Roberson ED. Mouse models of Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease. Brain Res Bull.</span></p>
<p style="top:269.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2012;88:3</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">12.</span></p>
<p style="top:278.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">44.</span></p>
<p style="top:278.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L. Low-carb and</span></p>
<p style="top:287.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">ketogenic diets in type 1 and type 2 diabetes. Nutrients. 2019;11.</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff"> https://</span></p>
<p style="top:296.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#0000ff">doi.org/10.3390/nu11050962</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">.</span></p>
<p style="top:305.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">45.</span></p>
<p style="top:305.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, et al.</span></p>
<p style="top:314.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Effects of low-carbohydrate vs low-fat diets on weight loss and</span></p>
<p style="top:323.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">cardiovascular risk factors: a meta-analysis of randomized controlled trials.</span></p>
<p style="top:332.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Arch Intern Med. 2006;166:285</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">93.</span></p>
<p style="top:341.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">46.</span></p>
<p style="top:341.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Castellano C-A, Nugent S, Paquet N, Tremblay S, Bocti C, Lacombe G, et al.</span></p>
<p style="top:350.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate</span></p>
<p style="top:359.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">metabolism in mild Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s disease dementia. J Alzheimers Dis JAD.</span></p>
<p style="top:368.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2015;43:1343</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">53.</span></p>
<p style="top:377.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">47.</span></p>
<p style="top:377.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Mart&#xed;nez-Lapiscina EH, Galbete C, Corella D, Toledo E, Buil-Cosiales P, Salas-</span></p>
<p style="top:386.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Salvado J, et al. Genotype patterns at CLU, CR1, PICALM and APOE,</span></p>
<p style="top:395.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">cognition and Mediterranean diet: the PREDIMED-NAVARRA trial. Genes</span></p>
<p style="top:404.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Nutr. 2014;9:393.</span></p>
<p style="top:413.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">48.</span></p>
<p style="top:413.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Mehta D, Jackson R, Paul G, Shi J, Sabbagh M. Why do trials for Alzheimer</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2019;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">s</span></p>
<p style="top:422.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">disease drugs keep failing? A discontinued drug perspective for 2010-2015.</span></p>
<p style="top:431.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Expert Opin Investig Drugs. 2017;26:735</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">9.</span></p>
<p style="top:440.5pt;left:304.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">49.</span></p>
<p style="top:440.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">Sanders CL, Wengreen HJ, Schwartz S, Behrens SJ, Corcoran C, Lyketsos CG,</span></p>
<p style="top:449.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">et al. Nutritional status is associated with severe dementia and mortality:</span></p>
<p style="top:458.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">the Cache County Dementia Progression Study. Alzheimer Dis Assoc Disord.</span></p>
<p style="top:467.5pt;left:319.7pt;line-height:7.3pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">2018;32:298</span><span style="font-family:GvwbjcAdvTTb5929f4c+20,serif;font-size:7.3pt;color:#131313">&#x2013;</span><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.3pt;color:#131313">304.</span></p>
<p style="top:489.1pt;left:304.7pt;line-height:10.3pt"><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">Publisher</span><span style="font-family:DswlnqAdvTTaf7f9f4f.B+20,serif;font-size:10.3pt;color:#131313">&#x2019;</span><span style="font-family:SbnyqsAdvTTaf7f9f4f.B,serif;font-size:10.3pt;color:#131313">s Note</span></p>
<p style="top:500.3pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">Springer Nature remains neutral with regard to jurisdictional claims in</span></p>
<p style="top:509.3pt;left:304.7pt;line-height:7.5pt"><span style="font-family:TvnsybAdvTTb5929f4c,serif;font-size:7.5pt;color:#131313">published maps and institutional affiliations.</span></p>
<p style="top:32.6pt;left:56.7pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Lilamand</span><span style="font-family:TfxqqpAdvTT7329fd89.I,serif;font-size:8.0pt;color:#131313"> et al. Alzheimer&apos;s Research &amp; Therapy</span><span style="font-family:MyriadPro,serif;font-size:8.0pt;color:#131313">           (2020) 12:42 </span></p>
<p style="top:32.6pt;left:492.0pt;line-height:8.0pt"><span style="font-family:HwstcrAdvTTe45e47d2,serif;font-size:8.0pt;color:#131313">Page 10 of 10</span></p>

</div>
